1. Editor's note

   • Daniel D. Von Hoff

   EditorialNotes Pages: 111 - 111

2. CI-921: An analog of amsacrine with experimental activity against solid tumors

   • William R. Grove
   • Linda W. DeLap
   • Antonio J. Grillo-López

   Preclinical Studies Pages: 113 - 118

3. The effects of bisantrene on human platelets

   • Mary Ellen Rybak
   • Beth Badstubner
   • Thomas Griffin

   Preclinical Studies Pages: 119 - 125

4. Investigation of the interaction of cardiotoxic anticancer agents using the fetal mouse heart organ culture system

   • Bruce F. Kimler
   • Richard D. Rethorst
   • Gail G. Cox

   Preclinical Studies Pages: 127 - 133

5. In vitro Chemosensitivity testing of human neuroblastoma cell lines in soft agar: A tumor — specific drug screening model

   • Michael F. Sarosdy
   • Sandra L. Schneider
   • Paul M. Zeltzer

   Preclinical Studies Pages: 135 - 139

6. Activity of 2-fluoro-Ara AMP against gynecologic tumors in the soft agar assay

   • Jaffer A. Ajani
   • Barbara Tomasovic
   • David Gershenson

   Preclinical Studies Pages: 141 - 148

7. Phase I clinical and pharmacokinetic study of bisantrene in refractory pediatric solid tumors

   • Charles B. Pratt
   • Joseph A. Sinkule
   • Loraine Avery

   OriginalPaper Pages: 149 - 153

8. Phase I trial of intraperitoneal chemotherapy with 5-fluorouracil and citrovorum factor

   • G. Thomas Budd
   • Martin J. Schreiber
   • James K. Weick

   OriginalPaper Pages: 155 - 158

9. Skin reactions induced by trimetrexate, an analog of methotrexate

   • Raymond B. Weiss
   • William D. James
   • Gregory A. Curt

   OriginalPaper Pages: 159 - 163

10. Phase II study of 4′-deoxydoxorubicin in advanced colorectal cancer

    • Geoffrey Falkson
    • Daniel A. Vorobiof

    OriginalPaper Pages: 165 - 169

11. Phase II trial of 10 deaza-aminopterin in patients with bladder cancer

    • Tauseef Ahmed
    • Alan Yagoda
    • Robin C. Watson

    OriginalPaper Pages: 171 - 174

12. Phase II trial of Nimustine (ACNU; 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride) in patients with small cell carcinoma of the lung after failure on combination chemotherapy

    • Rudolf A. Joss
    • Pierre Siegenthaler
    • Franco Cavalli

    OriginalPaper Pages: 175 - 179

13. A Phase II study of CHIP in advanced squamous cell carcinoma of the cervix (a Gynecologic Oncology Group study)

    • McGuire William P.
    • Blessing John A.
    • DiSaia Philip J.

    OriginalPaper Pages: 181 - 186

14. A Phase II study of carboplatin in advanced squamous cell carcinoma of the cervix (a Gynecologic Oncology Group study)

    • Arseneau James
    • Blessing John A.
    • McGehee Ramon

    OriginalPaper Pages: 187 - 191

15. Phase II trial of 4′-deoxydoxorubicin (esorubicin) in hormone resistant prostate cancer

    • Ted Braich
    • Frederick R. Ahmann
    • Sydney E. Salmon

    OriginalPaper Pages: 193 - 196

16. Errata

    Erratum Pages: 197 - 197

17. Fifth NCI-EORTC symposium on new drugs in cancer therapy

    Announcement Pages: 199 - 199